Advancing Treatment of Inflammatory and Autoimmune Diseases
Our Capabilities
Pharsight is the largest drug development modeling and simulation company in the world. Having engaged on nearly 350 projects in the past five years, Pharsight Strategic Consulting Services provides expert scientific capabilities to address critical development questions from preclinical testing to post-launch market surveillance. Pharsight resources include seasoned practitioners from industry, government, academia, and consulting. Our multidisciplinary team of more than 20 Ph.D. and MD scientists can optimize your drug development decisions through quantitative exploration of development knowledge and uncertainty that integrates drug/disease models, trial models, and predictive market models.
Leaders in Anti-Inflammatory and Immunomodulation Drug Development Consulting
Pharsight has supported many anti-inflammatory and autoimmune drug development programs for industry sponsors over the past five years, across multiple phases. Our experience includes extensive PK/PD modeling, analysis and trial design work in Rheumatoid Arthritis (RA), along with work in psoriasis and psoriatic disorders, Multiple Sclerosis (MS), and immunomodulating agents for organ transplant rejection.
Our public-source database in RA provides a ready context for model-based meta analysis to assess your compound's performance against competing therapies.